Kashanipour, Shiva L PA

Dana-Farber Cancer Institute, established in 1947, is dedicated to providing expert cancer care and pioneering treatments for both adult and pediatric patients. Renowned as New England's top-ranked cancer center for over 20 years, it specializes in individualized treatment plans and comprehensive support services tailored to each patient's unique needs. With a commitment to advancing cancer research, Dana-Farber ensures that breakthroughs in science translate into effective treatment options. The institute operates under the guiding principle of compassionate, patient-centered care, making it a leader in the fight against cancer. Generated from the website

Hemophilia is an inherited bleeding disorder in which the blood does not clot normally because of a missing or dysfunctional clotting protein. Clotting proteins, also called clotting factors, work with other blood components such as platelets, von Willebrand factor, and other proteins to form a blood clot. When any of these components is absent or low, increased bleeding can result. If clotting factor VIII (8) or factor IX (9) are affected, this bleeding disorder is called hemophilia.